Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Injectable GLP-1 medications such as Wegovy and Zepbound became popular because they helped many patients lose significant weight without surgery
Archives of Dermatological Research
Wegovy In a clinical trial of adults with overweight or obesity (without diabetes), once-weekly semaglutide (Wegovy) led to significantly greater weight loss over 68 weeks compared to once-daily liraglutide (Saxenda)
Hence, you stay on treatment long enough to see results
Rybelsus patients lost between 2.5% and 4.1% of their body weight on average
US$ 25.95
US$ 26.76
US$ 25.91
US$ 28.61
US$ 23.56
US$ 28.98
